Approval · Notice of Compliance 6290 · 2005
VALTREX: Notice of Compliance 6290
Issued February 18, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6290
- Date
- February 18, 2005
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALTREX | 02239130 | — |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 250 MG per TAB